Chytrid Fungus in Europe
To the Editor: Amphibian species are declining at an alarming rate on a global scale (1) . One of the major reasons for these declines is chytridiomycosis, caused by the chytridiomycete fungus, Batrachochytrium dendrobatidis (1, 2) . This pathogen of amphibians has recently emerged globally (2, 3) and has caused mass die-offs and extensive species declines on 4 continents (1,3); knowledge of its distribution and effects on amphibian populations remains poor. In Europe, little is known about B. dendrobatidis distribution, which is disturbing when one considers that at least 3 European amphibian species are undergoing chytrid-associated die-offs that will likely lead to local extinction (4,5) (J. Bosch et al., unpub. data).
We screened 1,664 current and archived samples of wild amphibians collected in Europe from 1994 to 2004 by researchers using amphibians as study organisms. B. dendrobatidis infects the skin of adult amphibians and the mouthparts of anuran larvae; samples included toe clippings and skin samples from adults and mouthparts of tadpoles. Our sampling was opportunistic, including both caudates and anurans. We screened all samples for chytrid fungus with quantitative real-time polymerase chain reaction (PCR) of the ITS-1/5.8S ribosomal DNA region of B. dendrobatidis (6) , including appropriate positive and negative controls. We confirmed realtime PCR positives by amplifying a subset of these positives with a second B. dendrobatidis-specific PCR with a nested reaction developed from the ctsyn1 locus (3). To confirm that detection with real-time PCR indicated a viable chytrid infection, when actual tissue samples were available, we examined a generous subset using histologic features for typical signals of pathogenic B. dendrobatidis infection. Specifically, we found intracellular zoospore-carrying sporangia within the stratum corneum and stratum granulosum of toe and skin samples. We also compared real-time PCR amplification profiles of suspected positives to those generated from samples from animals involved in chytrid-driven die-offs and found these results to be comparable. Furthermore, attempts to isolate the fungus from dead animals were successful when animals were obtained in a suitable condition for this purpose (see below).
Our survey found B. dendrobatidis in amphibians in 5 European countries, Spain, Portugal, Italy, Switzerland, and Great Britain. Previously, chytrid infection has been reported in wild amphibians only in Spain, Germany, and Italy (4, 5, 7, 8) . We detected chytrid fungus in 20 of 28 amphibian species examined, representing 9 different genera, 5 anuran, and 4 caudate, in 6 families. We found signs of chytrid in archived samples from as early as 1998. The number of infections per country we found were (5), respectively, and confirmed with scanning electron microscopy, histologic examination, and molecular detection methods (4, 5) . 
data).
This survey shows that B. dendrobatidis is widely and irregularly distributed in Europe and infects a broad range of amphibian species. Furthermore, because of the opportunistic nature of our sampling strategy, our results certainly underestimate the overall prevalence of B. dendrobatidis in Europe. These findings are surprising considering that chytridrelated die-offs have been infrequently described in Europe. This may be because B. dendrobatidis has only recently and rapidly expanded its range into Europe (3), and the consequences are only now being detected in wild amphibian populations; because the expression of chytridiomycosis is environmentally limited (11); or because European amphibians exhibit highly variable levels of resistance to chytrid infection. Notwithstanding, our knowledge of the epidemiology of B. dendrobatidis is insufficient to effectively manage wildlife and conduct disease abatement. As data regarding the distribution of chytrid fungus accumulate and the ecologic requirements for disease persistence and transmission are identified (11), management of the pathogen can become more predictive. Basic management practices, such as restricting transportation of potential carriers and restricting pet trading and reintroduction projects, coupled with field monitoring, must be improved to prevent further global emergence of this pathogen. Our results also show that asymptomatic amphibians must be included in any broad-scale epidemiologic screening for this emergent pathogen.
Vibrio metschnikovii Pneumonia
To the Editor: Vibrio metschnikovii is a gram-negative, oxidase-negative bacillus. This species was isolated in 1981 from blood culture of an 82-year-old diabetic woman with cholecystitis (1). It was previously isolated from river water, clams, oysters (2), fish (3), and birds that died of a choleralike illness (4). We report isolation of V. metschnikovii in bronchial aspirate from a patient with pneumonia.
A 63-year-old man was admitted to the intensive care unit (ICU) of A. Calmette hospital in Lille, France, for acute respiratory failure related to community-acquired pneumonia. The patient had a history of chronic obstructive pulmonary disease with a forced expiratory volume of 820 mL in 1 s (32% of predictive value); he was treated with oral salmeterol, terbutaline, and prednisolone (40 mg/day). He was HIV negative. On ICU admission, he had the following values: respiratory rate 30/min, temperature 39°C, pulse rate 140/min, blood pressure 140/90 mm Hg, Glasgow coma score 15, leukocyte count 13.7 × 10 9 /L, hemoglobin level 10.2 g/dL, procalcitonin level 22 ng/mL, and C-reactive protein level 73 mg/L. A chest radiograph showed diffuse bilateral infiltrates. Analysis of arterial blood gases with 6L of oxygen/min showed respiratory acidosis: pH 7.30, pCO 2 59 mm Hg, pO 2 78 mm Hg, HCO 3 23 mmol/L, O 2 saturation 94%. Other laboratory test results were normal. After noninvasive ventilation failed, the patient was immediately intubated and mechanically ventilated.
Blood cultures and bronchial aspirate samples were obtained before initiating treatment with antimicrobial drugs. The patient was treated with amoxicillin/clavulanic acid and ciprofloxacin. Blood cultures showed negative results. Microscopic examination of the bronchial aspirate showed no squamous epithelial cells, a few gram-negative bacilli, leukocytes, and many ciliated bronchial cells. The presence of ciliated cells was the best indicator that secretions originated from the lower respiratory tract. A urinary antigenic test result for Legionella spp. was negative. Quantitative culture of the bronchial aspirate on bromocresol purple agar, blood agar (grown in an atmosphere of 5% CO 2 ), and chocolate agar plates yielded V. metschnikovii (10 7 CFU/mL) and nonhemolytic streptococci (10 5 CFU/mL) as the oropharyngeal flora. These streptococci (gram-positive, catalase-negative) were not considered to be the pathogenic agent.
The strain of V. metschnikovii isolated was a gram-negative, curved rod. This facultative aeroanaerobic bacillus formed opaque colonies (diameter 3 mm) on blood agar in 24 h and showed complete hemolysis. It was catalase positive, oxidase negative, and did not reduce nitrate to nitrite. This strain was identified as V. metschnikovii with an ID GBN Vitek 2 card (bioMérieux, Marcy l'Etoile, France) (acceptable T identification index 0.22). Confirmation was done with a Microseq 500 16S ribosomal DNA bacterial kit (PE Applied Biosystems, Foster City, CA, USA). A 475-bp fragment was sequenced in an automated sequencer (360 ABI Prism, PE Applied Biosystems). The fragment was compared with National Center for Biotechnology Information (Bethesda, MD, USA) GenBank entries and showed 99% homology with V. metschnikovii (GenBank accession no. X74712.1). In vitro susceptibility testing with the AST-N032 Vitek 2 card (bioMérieux) showed that the organism was resistant to ampicillin, ticarcillin, piperacillin, and aminoglycosides.
